Vol. 2 No. 2 (2024), Articles
Vol. 2 No. 2 (2024)

Navigating Blistering Pathways: A Case Study of Dyshidrosiform Bullous Pemphigoid

Articles
Published 2024-09-14
Ashna Khare
Texas Tech University Health Sciences Center, School of Medicine
Kritin K. Verma
Texas Tech University Health Sciences Center, School of Medicine
Fatma Zeynep Deligonui
University of Incarnate Word School of Osteopathic Medicine
Ethan Matthew
Department of Dermatology, Texas Tech University Health Sciences Center
Kristina Blegen
Department of Dermatology, Texas Tech University Health Sciences Center
Michelle Tarbox
Department of Dermatology, Texas Tech University Health Sciences Center

How to Cite

1.
Khare A, K. Verma K, Zeynep Deligonui F, Matthew E, Blegen K, Tarbox M. Navigating Blistering Pathways: A Case Study of Dyshidrosiform Bullous Pemphigoid. Journal of Clinical Dermatology and Surgery. 2024;2(2). doi:10.61853/bh5k0d18
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Dyshidrosiform Bullous Pemphigoid (DBP) is a rare type of autoimmune blistering disease, mainly affecting elderly individuals. Causing pruritic blisters on the palms and soles, it can be challenging to differentiate from other conditions such as pompholyx. A case study of an 89-year-old patient with DBP is presented, emphasizing the importance of accurate diagnosis through techniques like direct immunofluorescence (DIF) staining. Treatment typically involves corticosteroids, monoclonal antibodies, dapsone, or immunosuppressants. Improved awareness and understanding of DBP are crucial for improved patient outcomes.